← Leaderboards
Darryl Grendahl
Mayo Clinic Coll Of Medicine, Rochester
$1,701,081
Attributed
$1,701,081
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.5K · FY2005–13$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,701,081 · 3
By mechanism
P30$1,701,081 · 3
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Thomas A Sellers$29,875,707
- Charles L Loprinzi$16,465,874
- Matthew M Ames$2,386,221
- Richard M Goldberg$4,114,970
- Stephen M Ansell$7,057,055
Others in their field
Top investigators on “Oncology”
- Larry Arthur$365,424,300
- David Heimbrook · Leidos Biomedical Research, Inc.$284,312,591
- Gregory H Reaman · National Childhood Cancer Foundation$243,308,665
- Norman Wolmark · Nsabp Foundation, Inc.$233,216,600
- Charles A Coltman · Southwest Oncology Group$199,580,977
- Peter C Adamson · National Childhood Cancer Foundation$192,690,226
Research focus
OncologyNeoplasm /CancerClinical TrialsHospitalsEquipment And Supply InventoriesHematologyEnsureComputerizedDoseAdultClinical ResearchBody Surface AreaGuidelinesHealth SystemBiomedical FacilityAdmixtureAccountabilityCancer CenterAmericanChemotherapyChildhoodClinicAdverse EventDesign
Grant awards (15)
Pharmacy$142,797
P30 · FY2013 · CA · contact PI
Pharmacy$169,506
P30 · FY2012 · CA · contact PI
Pharmacy$146,877
P30 · FY2011 · CA · contact PI
Pharmacy$155,262
P30 · FY2010 · CA · contact PI
Pharmacy$153,289
P30 · FY2009 · CA · contact PI
CORE--PHARMACY$148,580
P30 · FY2008 · CA · contact PI
CORE--PHARMACY$146,497
P30 · FY2007 · CA · contact PI
CORE--PHARMACY$79,168
P30 · FY2006 · CA · contact PI
CORE--PHARMACY$76,861
P30 · FY2005 · CA
CORE--PHARMACY$109,325
P30 · FY2004 · CA
CORE--PHARMACY$72,259
P30 · FY2002 · CA
CORE--PHARMACY$228,401
P30 · FY2001 · CA
CORE--PHARMACY$72,259
P30 · FY2001 · CA
CORE--PHARMACY$0
P30 · FY2000 · CA
CORE--PHARMACY$0
P30 · FY2000 · CA